| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥197.8B | ¥220.4B | -10.3% |
| Operating Income | ¥11.7B | ¥22.4B | -47.8% |
| Ordinary Income | ¥6.8B | ¥16.8B | -59.5% |
| Net Income | ¥5.7B | ¥13.8B | -58.9% |
| ROE | 8.9% | 24.4% | - |
FY2025 results: Revenue ¥197.8B (YoY -10.3%), Operating Income ¥11.7B (YoY -47.8%), Ordinary Income ¥6.8B (YoY -59.5%), Net Income ¥5.7B (YoY -58.9%). The company experienced significant deterioration across all profit metrics despite strong operating cash flow generation of ¥36.9B (+25.2% YoY). Revenue contraction was driven by lower wax product sales volume and heavy fuel oil sales decline. Profitability was severely compressed by declining gross margin (18.0% vs 20.8% prior year) and elevated interest expense of ¥5.7B, reflecting the burden of ¥15.6B in interest-bearing debt concentrated in short-term borrowings. The company operates a single segment business focused on wax and related products manufacturing and sales, with Japan representing 72.1% of total revenue.
Revenue declined ¥22.7B (-10.3%) to ¥197.8B, primarily driven by wax product sales decreasing from ¥201.9B to ¥187.3B and heavy fuel oil sales declining from ¥17.0B to ¥9.4B (-45.1%). Geographic breakdown shows domestic Japan sales fell from ¥155.0B to ¥142.7B (-7.9%), North America from ¥11.0B to ¥8.2B (-25.5%), and Asia excluding Japan from ¥46.7B to ¥41.5B (-11.1%). The revenue contraction reflects both volume decline and lower selling prices amid softer market conditions. Cost of sales decreased to ¥162.3B but at a slower pace than revenue, resulting in gross profit compression to ¥35.5B (margin 18.0% vs 20.8% prior). SG&A expenses remained relatively stable at ¥23.8B (+2.1%), causing the SG&A ratio to increase to 12.0% from 10.6%. Operating income consequently fell ¥10.7B (-47.8%) to ¥11.7B with operating margin deteriorating 4.3 percentage points to 5.9%.
Non-operating expenses significantly impacted profitability, with interest expense of ¥5.7B remaining elevated and nearly unchanged YoY, representing a substantial 48.6% of operating income. Non-operating income totaled ¥1.1B including FX gains of ¥0.3B and dividend income of ¥0.1B. The net non-operating expense of ¥4.9B resulted in ordinary income of ¥6.8B, down ¥10.0B (-59.5%) YoY. Extraordinary items included impairment loss of ¥0.5B (vs ¥0.2B prior) and loss on disposal of fixed assets of ¥0.2B. Income tax expense reflected a credit of ¥0.8B (deferred tax benefit of ¥0.9B offset by current tax of ¥0.2B) due to loss carryforwards, resulting in net income of ¥5.7B. The extraordinary and tax effects created a material gap between ordinary income (¥6.8B) and net income (¥5.7B), with the tax credit partially offsetting the deterioration. This represents a "revenue down/profit down" pattern with margin compression across all levels due to operating deleverage and structural cost burdens.
The company operates a single business segment of wax and related products manufacturing and sales, therefore segment-level operating profit analysis is not applicable. Product category breakdown shows wax products generated ¥187.3B (94.7% of revenue), heavy fuel oil ¥9.4B (4.7%), and other products ¥1.1B (0.6%). Geographic revenue composition indicates Japan as the core market with ¥142.7B (72.1%), followed by Asia excluding Japan ¥41.5B (21.0%), North America ¥8.2B (4.1%), and other regions ¥5.4B (2.7%). The dominant product concentration in wax and geographic concentration in Japan represent both the company's competitive positioning and structural dependency risks.
[Profitability] ROE 8.9% deteriorated from prior year levels, reflecting compressed net profit margin of 2.9% (net income ¥5.7B / revenue ¥197.8B). Operating margin of 5.9% declined 4.3 percentage points from 10.2% YoY, significantly below manufacturing industry benchmarks. Gross margin compressed to 18.0% from 20.8%, indicating pricing pressure and operating deleverage. Interest burden coefficient (profit before tax/EBIT) of 0.529 indicates approximately 47% of operating profit consumed by net non-operating expenses, primarily interest costs. EBITDA of ¥20.3B (operating income ¥11.7B + D&A ¥8.6B) yields an EBITDA margin of 10.3%. [Cash Quality] Cash and deposits stood at ¥28.3B, providing 0.24x coverage of short-term debt of ¥120.1B (short-term loans ¥120.0B + current portion of long-term debt ¥0.1B). Operating cash flow of ¥36.9B represents 5.29x net income, indicating strong accrual quality with significant positive adjustments from inventory reduction (¥23.1B) and depreciation (¥8.6B). Free cash flow of ¥30.9B (operating CF ¥36.9B less investing CF ¥6.0B) demonstrates robust cash generation despite profit deterioration. [Investment Efficiency] Asset turnover of 0.725x (revenue ¥197.8B / average assets ¥272.8B) declined from approximately 0.74x, reflecting revenue contraction. Inventory stands at ¥49.3B (18.1% of assets), with days inventory outstanding of 111 days indicating slow turnover. Property, plant and equipment of ¥138.7B represents significant capital intensity. Capex of ¥5.0B relative to depreciation of ¥8.6B yields a capex/depreciation ratio of 0.58x, suggesting potential underinvestment in asset renewal. [Financial Health] Equity ratio of 23.4% (equity ¥63.8B / assets ¥272.8B) improved from 19.1%, but remains low indicating high financial leverage. Current ratio of 90.3% (current assets ¥125.1B / current liabilities ¥138.6B) falls below 1.0x, indicating insufficient short-term liquidity. Quick ratio of 54.7% excludes inventories and signals liquidity strain. Debt-to-equity ratio of 3.28x (interest-bearing debt ¥156.0B / equity ¥63.8B) represents elevated leverage. Total interest-bearing debt comprises short-term loans ¥120.0B, current portion ¥0.1B, and long-term debt ¥36.0B. Debt-to-EBITDA of 7.67x significantly exceeds typical covenant thresholds. Interest coverage of 2.07x (EBIT ¥11.7B / interest ¥5.7B) indicates thin cushion for debt service.
Operating cash flow of ¥36.9B represents a 25.2% increase YoY despite significant profit decline, reflecting strong working capital management. Operating CF subtotal before working capital changes of ¥42.4B comprised net income adjusted for depreciation ¥8.6B, impairment ¥0.5B, and other non-cash items. Working capital movements contributed ¥5.5B with inventory decrease of ¥23.1B (conversion of stock to cash) and trade receivables decrease of ¥3.5B, partially offset by trade payables decrease of ¥5.2B reflecting supplier payment timing. Investing cash flow of negative ¥6.0B was primarily capital expenditures of ¥5.0B, representing 0.58x depreciation and suggesting maintenance-level investment. Interest and dividends received totaled ¥0.2B. Financing cash flow of negative ¥27.3B reflected net repayment of short-term loans of ¥11.8B, long-term loan repayment of ¥15.1B, and interest paid of ¥5.7B, partially offset by new long-term borrowings of ¥0.3B. No dividends were paid during the period. Free cash flow of ¥30.9B indicates capacity for debt reduction despite restricted liquidity ratios. Cash and equivalents increased ¥4.3B to ¥27.3B after accounting for exchange effects of ¥0.7B. The cash conversion cycle deteriorated with days inventory outstanding at 111 days, days sales outstanding at 43 days, and days payables outstanding at 14 days, yielding a cash conversion cycle of approximately 140 days, indicating extended working capital requirements.
Ordinary income of ¥6.8B versus operating income of ¥11.7B shows net non-operating expense of approximately ¥4.9B, representing a significant 42% reduction from operating profit. Non-operating expenses totaling ¥6.0B comprise primarily interest expense of ¥5.7B (94.5% of non-operating expenses) and FX losses of ¥0.3B, while non-operating income of ¥1.1B includes FX gains of ¥0.3B, dividend income of ¥0.1B, and rental income of ¥0.2B. The interest expense represents 2.9% of revenue and 48.6% of operating income, indicating structural burden from debt financing. Comprehensive income of ¥7.0B exceeded net income of ¥5.7B by ¥1.3B, with foreign currency translation adjustment of ¥0.8B and revaluation reserve adjustments contributing to other comprehensive income. Operating cash flow of ¥36.9B substantially exceeds net income of ¥5.7B by 6.5x, indicating high earnings quality from a cash perspective, primarily driven by inventory conversion and depreciation add-back. However, the significant inventory reduction of ¥23.1B represents one-time working capital release rather than sustainable operational improvement. Accruals analysis shows working capital provided ¥5.5B net positive contribution to operating CF, suggesting earnings are well-supported by cash generation. The negative tax expense (tax benefit) of ¥0.8B relative to profit before tax of ¥6.2B indicates utilization of deferred tax assets and loss carryforwards, which may not recur. Excluding the inventory liquidation effect, normalized operating CF would approximate ¥13.8B, still healthy at 1.97x net income but substantially lower than reported. Core earnings quality is solid but leverage and interest burden create significant financial risk overlay.
Full-year forecast projects revenue of ¥211.0B (+6.7% YoY), operating income of ¥18.0B (+53.4% YoY), ordinary income of ¥13.0B (+91.0% YoY), and EPS of ¥40.51. Current achievement rates against full-year guidance are: revenue 93.7%, operating income 65.1%, and ordinary income 52.3%. The revenue progress rate of 93.7% indicates near-complete fulfillment, while operating income at 65.1% and ordinary income at 52.3% suggest backend-weighted profitability recovery or conservative initial guidance. The implied remaining period requires revenue of ¥13.2B and operating income of ¥6.3B to meet targets. Guidance assumes improvement in sales volume, gross margin recovery through pricing and cost management, and stable non-operating expenses. The 53.4% operating income growth projection implies significant margin expansion from 5.9% to approximately 8.5%, requiring substantial operational improvements including absorption of fixed costs through volume recovery, material cost reduction, and operational efficiency gains. Management notes indicate the forecast is based on current information and assumptions subject to change due to market conditions. No order backlog data is disclosed for forward revenue visibility assessment. The achievement of profitability targets depends critically on revenue recovery materializing and gross margin restoration, while the high interest burden of approximately ¥5.7B annually will continue to constrain net profitability unless debt levels are reduced.
The company paid no dividends for the fiscal year, with both interim and year-end dividends at ¥0 per share, unchanged from the prior year. Payout ratio is not applicable given zero dividend distribution. No share buyback activities were disclosed during the period. Total return ratio to shareholders is consequently 0%. Free cash flow of ¥30.9B provides technical capacity for shareholder returns, however management priority appears directed toward debt reduction and balance sheet strengthening given the stressed liquidity position with current ratio below 1.0x and elevated leverage ratios. The company's equity per share increased to ¥322.97 from ¥287.30, reflecting retained earnings accumulation despite the absence of dividend payments. Treasury stock remained unchanged at ¥6.7B. Given the financial structure constraints including Debt/EBITDA of 7.67x and interest coverage of only 2.07x, the zero dividend policy appears prudent to preserve cash for debt service and refinancing needs. Future dividend resumption would require sustained profitability improvement, debt reduction to sustainable levels, and achievement of target financial metrics including adequate liquidity cushions and interest coverage ratios. The forecast EPS of ¥40.51 for the coming year suggests potential for dividend consideration if targets are achieved and financial health metrics improve, though no explicit dividend policy guidance has been provided by management.
Revenue concentration risk: Single segment business with 94.7% revenue from wax products and 72.1% from Japan market creates substantial exposure to product-specific and domestic market dynamics. Any deterioration in wax demand, competitive pricing pressure, or Japanese economic slowdown would directly impact financial performance. Geographic diversification remains limited with international markets contributing only 27.9% of revenue. Quantified impact: Revenue declined 10.3% in current period with wax sales down from ¥201.9B to ¥187.3B, demonstrating vulnerability to market conditions.
Refinancing and liquidity risk: Short-term debt concentration of ¥120.1B against cash of only ¥28.3B (0.24x coverage) with current ratio of 90.3% creates acute refinancing risk. Approximately 76.9% of total debt is short-term, requiring continuous rollover. Rising interest rates or credit tightening could materially impact refinancing capability and costs. Interest expense of ¥5.7B annually represents 48.6% of operating income, leaving minimal cushion. Quantified impact: Debt/EBITDA of 7.67x exceeds typical covenant thresholds (usually 3.0-4.0x), and interest coverage of 2.07x provides limited buffer. A 1 percentage point increase in borrowing rates would increase annual interest by approximately ¥1.6B, consuming 13.4% of current operating income.
Inventory and working capital risk: Inventory balance of ¥49.3B represents 111 days inventory outstanding, indicating slow turnover and potential obsolescence risk. The current period benefited from ¥23.1B inventory reduction contributing to operating cash flow, which may not be repeatable. Working capital represents 18.1% of total assets and ties up significant capital. Extended cash conversion cycle of approximately 140 days strains liquidity. Quantified impact: If inventory increases to prior year levels of ¥64.0B, cash would decline by ¥14.7B, reducing cash/short-term debt coverage from 0.24x to 0.11x and further tightening liquidity. Inventory write-downs of even 5% would impact profit by ¥2.5B, exceeding net income of ¥5.7B.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: Operating margin of 5.9% (2025) has declined from prior period 10.2% and represents below-median performance for specialized chemical manufacturers. The company's gross margin of 18.0% reflects capital-intensive wax refining operations with limited pricing power. ROE of 8.9% is leveraged by high debt levels (D/E 3.28x) rather than operational excellence, with net profit margin of only 2.9% constrained by heavy interest burden. Industry context indicates specialized petroleum product refiners typically achieve operating margins in the 8-12% range and ROE of 10-15% with more balanced capital structures.
Financial Health: Equity ratio of 23.4% falls substantially below industry median levels of 40-50% for manufacturing companies, indicating aggressive leverage. Current ratio of 90.3% is critically below the 1.0x minimum threshold and industry standard of 1.5-2.0x. Debt-to-EBITDA of 7.67x significantly exceeds industry acceptable ranges of 2.0-3.0x. The company's interest coverage of 2.07x is near minimum acceptable levels compared to industry median of 5.0x or higher.
Efficiency: Asset turnover of 0.725x aligns with capital-intensive refining operations but inventory days of 111 indicate suboptimal working capital management versus industry benchmarks of 60-90 days. Cash conversion cycle of approximately 140 days exceeds typical industrial company ranges of 60-90 days, indicating room for improvement in receivables collection and inventory turnover.
Liquidity and Cash Generation: Operating cash flow margin of 18.7% (operating CF ¥36.9B / revenue ¥197.8B) is robust and above industry averages of 8-12%, reflecting strong underlying cash generation despite profit compression. However, this was significantly aided by one-time inventory reduction. Free cash flow yield of 15.6% demonstrates strong conversion capability when normalized operations resume.
Reference: Proprietary analysis of specialized chemical and petroleum product manufacturers, based on publicly available financial data from comparable listed companies in the wax and petroleum specialty products sectors.
Operating cash generation strength provides fundamental resilience: Operating CF of ¥36.9B representing 5.29x net income and FCF of ¥30.9B demonstrate that underlying business operations generate substantial cash despite compressed accounting profitability. The operating CF margin of 18.7% significantly exceeds the net profit margin of 2.9%, indicating that the profit deterioration is heavily influenced by non-cash charges and financial structure rather than core operational weakness. This cash generation capability, even after adjusting for the one-time inventory reduction benefit of ¥23.1B, provides the company with financial flexibility to address leverage concerns and supports potential profitability recovery as guided.
Financial structure and leverage concentration create elevated risk requiring monitoring: The company's capital structure shows critical vulnerabilities with current ratio of 90.3%, cash coverage of short-term debt at only 0.24x, and 76.9% of total debt maturing within one year (¥120.1B of ¥156.0B). Debt/EBITDA of 7.67x and interest expense consuming 48.6% of operating income indicate unsustainable leverage levels requiring deleveraging. The ¥14.8B reduction in long-term debt from ¥50.8B to ¥36.0B alongside stable short-term borrowings suggests refinancing pressure and potential covenant constraints. Near-term refinancing execution and interest rate environment will be critical determinants of financial stability and profit trajectory.
Margin recovery pathway depends on volume normalization and structural cost management: The 4.3 percentage point operating margin compression from 10.2% to 5.9% resulted from revenue decline of 10.3% combined with fixed cost deleveraging and gross margin deterioration to 18.0% from 20.8%. Management guidance projecting operating income growth of 53.4% to ¥18.0B implies margin recovery to approximately 8.5%, requiring successful execution on volume recovery, pricing realization, and cost structure optimization. The single-segment concentration in wax products (94.7% of revenue) and Japan market dominance (72.1% of revenue) mean recovery is directly tied to specific market conditions. Achievement of forecast profitability would restore interest coverage to more sustainable levels and support gradual deleveraging, while shortfalls would further strain financial flexibility. Investors should monitor quarterly progress rates, working capital normalization (particularly inventory levels returning from current ¥49.3B), and debt refinancing terms as key indicators of the turnaround trajectory.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.